PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver Diseases. [PDF]
Gallucci GM +5 more
europepmc +1 more source
Urinary metabolome dynamics in <sup>13</sup>C-labeled mice. [PDF]
Damont A +9 more
europepmc +1 more source
From rumen to milk: Dietary polyphenols in dairy cows-A critical review. [PDF]
Forte L +9 more
europepmc +1 more source
Bile acid therapy for primary biliary cholangitis: Pathogenetic validation. [PDF]
Reshetnyak VI, Maev IV.
europepmc +1 more source
Characterizing the metabolites of the tyrosine-kinase inhibitor pexidartinib in mouse feces, urine, plasma, and liver. [PDF]
Qin X +8 more
europepmc +1 more source
Mycotoxins - Determination of deoxynivalenol and deepoxydeoxynivalenol in urine by LC-MS/MS: Biomonitoring Method - Translation of the German version from 2025. [PDF]
Berger M +6 more
europepmc +1 more source
Cross-Signal Contribution as a Challenge in LC-MS/MS Bioanalysis. [PDF]
Siemiątkowska A +5 more
europepmc +1 more source
Safety and Effectiveness of Pharmacy Compounded Chenodeoxycholic Acid Capsules for Patients With Cerebrotendinous Xanthomatosis. [PDF]
Bouwhuis N +9 more
europepmc +1 more source
Studies on the Stability and Microbial Biotransformation of Five Deschloroketamine Derivatives as Prerequisite for Wastewater-Based Epidemiology Screening. [PDF]
Frankenfeld F, Wagmann L, Meyer MR.
europepmc +1 more source
Glucuronide metabolites of trans-ε-viniferin decrease triglycerides accumulation in an in vitro model of hepatic steatosis. [PDF]
Beaumont P +6 more
europepmc +1 more source

